RANI insider transaction filings

Rani Therapeutics Holdings, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen RANI transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 6 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Imran Talat — Chief Executive Officer, Director21 leg · 35,000 sh · $25,1931 leg · 8,014 sh · $11,3006
IMRAN MIR A — Director, 10% owner11 leg · 36,000 sh · $24,840
Javadi Alireza — Chief Technical Officer11 leg · 386 sh · $3011
Gilson Michelle — Director11
Maestas Nicholas — Chief Financial Officer11

Recent Form 4 filings — Rani Therapeutics Holdings, Inc.

FiledFormInsiderReported transactionsSource
2026-08-044Gilson Michelle — DirectorGrant/award (A): 247,200 (derivative) @ $0EDGAR
2026-07-234IMRAN MIR A — Director, 10% ownerPurchase (P): 36,000 @ $0.69EDGAR
2026-07-214Javadi Alireza — Chief Technical OfficerSale (S): 386 @ $0.78 · Tax withholding (F): 309 @ $0.74EDGAR
2026-07-214Maestas Nicholas — Chief Financial OfficerGrant/award (A): 2,000,000 (derivative) @ $0EDGAR
2026-07-214Imran Talat — Chief Executive Officer, DirectorPurchase (P): 35,000 @ $0.72EDGAR
2026-07-214Imran Talat — Chief Executive Officer, DirectorSale (S): 8,014 @ $1.41 · Tax withholding (F): 9,076 @ $0.55 · Tax withholding (F): 9,077 @ $0.48 · Tax withholding (F): 7,906 @ $1.40 · Tax withholding (F): 8,916 @ $1.13 · Tax withholding (F): 9,099 @ $0.81 · +1 moreEDGAR
2026-06-054Javadi Alireza — Chief Technical OfficerGrant/award (A): 805,500 (derivative) @ $0EDGAR
2026-06-054McKinley Kate — Chief Business OfficerGrant/award (A): 805,500 (derivative) @ $0EDGAR
2026-06-054Imran Talat — Chief Executive Officer, DirectorGrant/award (A): 3,800,000 (derivative) @ $0EDGAR
2026-06-014Bailey Vasudev Jaiprakash — DirectorGrant/award (A): 123,600 (derivative) @ $0EDGAR
2026-06-014Rometty Lisa Ann — DirectorGrant/award (A): 123,600 (derivative) @ $0EDGAR
2026-06-014Bassan Abraham — DirectorGrant/award (A): 123,600 (derivative) @ $0EDGAR
2026-06-014Ausiello Dennis A — DirectorGrant/award (A): 123,600 (derivative) @ $0EDGAR
2026-06-014BUTEL JEAN LUC — DirectorGrant/award (A): 123,600 (derivative) @ $0EDGAR
2026-06-014IMRAN MIR A — Director, 10% ownerGrant/award (A): 123,600 (derivative) @ $0EDGAR
2025-10-304Bailey Vasudev Jaiprakash — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-10-274Bassan Abraham — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-10-274IMRAN MIR A — Director, 10% ownerPurchase (P): 2,083,334 @ $0.60 · Purchase (P): 2,083,334 (derivative) @ $0EDGAR
2025-10-224South Cone Investments Limited Partnership — 10% ownerSale (S): 1,923,000 @ $2.41 · Sale (S): 4,000,000 @ $2.77EDGAR
2025-08-054McKinley Kate — Chief Business OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-05-304Rometty Lisa Ann — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-304Farquharson Andrew — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-304Nanavaty Maulik — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-304Ausiello Dennis A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-304BUTEL JEAN LUC — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-304IMRAN MIR A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-234Hashim Mir — Chief Scientific OfficerGrant/award (A): 325,000 (derivative) @ $0EDGAR
2025-05-234McKinley Kate — Chief Business OfficerGrant/award (A): 325,000 (derivative) @ $0EDGAR
2025-05-234Imran Talat — Chief Executive Officer, DirectorGrant/award (A): 1,053,000 (derivative) @ $0EDGAR
2025-05-234Sanford Svai S — Chief Financial OfficerGrant/award (A): 325,000 (derivative) @ $0EDGAR
2024-12-174Rometty Lisa Ann — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative) · Disposition to issuer (D): 17,708 (derivative) · Grant/award (A): 17,708 (derivative)EDGAR
2024-12-174Farquharson Andrew — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative)EDGAR
2024-12-174Nanavaty Maulik — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative) · Disposition to issuer (D): 15,423 (derivative) · Grant/award (A): 15,423 (derivative)EDGAR
2024-12-174Ausiello Dennis A — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative) · Disposition to issuer (D): 15,423 (derivative) · Grant/award (A): 15,423 (derivative)EDGAR
2024-12-174BUTEL JEAN LUC — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative) · Disposition to issuer (D): 18,875 (derivative) · Grant/award (A): 18,875 (derivative)EDGAR
2024-12-174DEBUONO LAUREEN — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative) · Disposition to issuer (D): 18,875 (derivative) · Grant/award (A): 18,875 (derivative)EDGAR
2024-12-174IMRAN MIR A — DirectorDisposition to issuer (D): 101,276 (derivative) · Grant/award (A): 101,276 (derivative)EDGAR
2024-12-164McKinley Kate — Chief Business OfficerPurchase (P): 17,960 @ $1.67EDGAR
2024-12-104Imran Talat — Chief Executive Officer, DirectorPurchase (P): 10,296 @ $1.94EDGAR
2024-10-174South Cone Investments Limited Partnership — 10% owner
South Lake One LLC — 10% owner
Sale (S): 3,305,622 @ $2.55 · Sale (S): 523,738 @ $3.26EDGAR
2024-05-304Farquharson Andrew — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304Rometty Lisa Ann — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304Nanavaty Maulik — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304Ausiello Dennis A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304BUTEL JEAN LUC — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304DEBUONO LAUREEN — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304IMRAN MIR A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-224Groen Eric — General CounselGrant/award (A): 323,500 (derivative) @ $0EDGAR
2024-03-224Hashim Mir — Chief Scientific OfficerGrant/award (A): 323,500 (derivative) @ $0EDGAR
2024-03-224Sanford Svai S — Chief Financial OfficerGrant/award (A): 323,500 (derivative) @ $0EDGAR

Recent 8-K events — Rani Therapeutics Holdings, Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-298-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K2.02 — Results of Operations and Financial Condition
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-028-K1.02 — Termination of a Material Definitive Agreement
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-278-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RANI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →